Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Down 16.7% in December

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 4,500 shares, a decline of 16.7% from the December 15th total of 5,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Shares of LABFF remained flat at C$65.86 during midday trading on Friday. The company’s 50-day simple moving average is C$71.31 and its 200-day simple moving average is C$83.91. Laboratorios Farmaceuticos Rovi has a 52-week low of C$65.86 and a 52-week high of C$65.86.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.